Use of hypofractionated radiotherapy regimens after organ-sparing surgery for Stages I–IIA breast cancers
https://doi.org/10.17650/1994-4098-2010-0-2-26-30
Abstract
There have been recent reports on the expediency of applying postoperative hypofractionated accelerated radiotherapy (RT) regimens in patients who have undergone breast-sparing surgery. The concept of accelerated hypofractionation (AH) includes daily high-dose radiation for a shorter total period of time. In most radiologists’ opinion, the AH RT regimen may be as effective as more conventional treatments that use lower daily radiation doses for a longer period. The appeal of this method is that shorter treatment provides more convenience for patients. By taking into account the fact that the α/β ratio for intact breast tissues is about 3.5 Gy, larger fraction RT regi- mens are likely to be more effective, which will reduce the frequency of recurrences as compared with conventional therapy approaches without increasing the incidence of postradiation intact tissue damage.
About the Authors
Yu. V. Efimkina
Department of Radiosurgery, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
I. A. Gladilina
Department of Radiosurgery, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
M. I. Nechushkin
Department of Radiosurgery, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
References
1. Давыдов М.И., Аксель Е.М. Статистика злокачественных новообразований в России и странах СНГ в 2004 г. Вестн РОНЦ им. Н.Н. Блохина РАМН 2008; 15(2):10–2, 24–6, 57–8, 63–4.
2. Давыдов М.И., Летягин В.П. Практическая маммология. М., 2007; с. 106–15.
3. Silva O.E., Zurrida S. Breast Cancer: a practical guide. 3rd ed. NY: Elsevier, 2005; p. 171–84.
4. Truong P.T., Jones S.O., Kader H.A., Wai E.S. Patients with T1 to T2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy. Int J Radiat Oncol Biol Phys 2009;73(2):357–64 .
5. Goldhirsch A., Glick J.H., Gelber R.D. et al. Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005; ESO – Moscow breast cancer forum, 2005; p. 3–17.
6. Hannan L., Spierer M., Skinner W. et al. Hypofractionated whole breast radiation therapy for large-breasted patients. Proceedings of the 51st Annual ASTRO Meeting No2095. Jnt J Radiat Oncol Biol Phys 2009; 75(3 Suppl):223.
7. Чехонадский В.Н. Радиационно- биофизические основы сочетанного облучения онкологических больных. Автореф. дис. ... д-р биол. наук. М., 1999.
8. Yarnold J., Owen R., Ashton A. et al. Fractionation sensitivity of change in breast appearance after radiotherapy for early breast cancer: results of a phase III randomised trial. Abstracts – Poster Session I 24th Annual San Antonio Breast Cancer Symposium, 2001; p. 154.
9. Yarnold J., Ashton A., Bliss J. et al. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long- term results of a randomized trial. Radiother Oncol 2005;75(1):9–17.
10. Whelan T., Clark R., Roberts R. et al. Ipsilateral breast tumor recurrence postlumpectomy is predictive of subsequent mortality. Results from a randomized trial. Int J Radiat Oncol Biol Phys 1994;30:11–6.
11. Baillet F., Housset M., Maylin C. et al. The use of a specific hypofractionated radiation therapy regimen versus classical fractionation in the treatment of breast cancer: A randomized study of 230 patients. Int J Radiat Oncol Biol Phys 1999;19:1131–3.
12. Chadha M., Woode R., Sillanpaa J. et al. Three-week accelerated radiation therapy (ART) schedule with a concomitan2t in-field boost as treatment for early stage breast cancer. Int J Radiat Oncol Biol Phys 2007;69:137.
13. Freedman G.M., Anderson P., Litwin S. et al. Four-week course of radiation for breast cancer using hypo fractionated intensity modulated radiation therapy with an incorporated boost. Proceedings of the 51st Annual ASTRO Meeting No163. Int J Radiat Oncol Biol Phys 2009;75(3 Suppl):77.
14. Saha S., Ghosh Dastidar A., Ghanem M. et al. Patterns of recurrence and nodal staging in rectal cancer patients undergoing sentinel lymph node mapping compared to conventional surgery. Int J Radiat Oncol Biol Phys 2009;75(3 Suppl):166–7.
15. Karasawa K., Ozawa S., Yamaguchi S. Int Proceedings of the 51st Annual ASTRO Meeting N2011. Int J Radiat Oncol Biol Phys 2009;75(3 Suppl):185.
Review
For citations:
Efimkina Yu.V., Gladilina I.A., Nechushkin M.I. Use of hypofractionated radiotherapy regimens after organ-sparing surgery for Stages I–IIA breast cancers. Tumors of female reproductive system. 2010;(2):26-30. (In Russ.) https://doi.org/10.17650/1994-4098-2010-0-2-26-30
Views:
685
Email this article 